Showing 18,121 - 18,140 results of 18,229 for search 'significantly ((((((greater decrease) OR (a decrease))) OR (nn decrease))) OR (linear decrease))', query time: 0.65s Refine Results
  1. 18121

    Table12_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

    Published 2024
    “…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”
  2. 18122

    Table3_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

    Published 2024
    “…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”
  3. 18123

    Table9_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

    Published 2024
    “…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”
  4. 18124

    Image1_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.tif by Yifang He (18126257)

    Published 2024
    “…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”
  5. 18125

    Table7_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

    Published 2024
    “…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”
  6. 18126

    Table6_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

    Published 2024
    “…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”
  7. 18127

    Table11_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

    Published 2024
    “…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”
  8. 18128

    Table8_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

    Published 2024
    “…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”
  9. 18129

    Table5_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

    Published 2024
    “…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”
  10. 18130

    Table10_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

    Published 2024
    “…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”
  11. 18131

    Table1_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

    Published 2024
    “…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”
  12. 18132

    Data sources and descriptions. by Zeduo Zou (21672789)

    Published 2025
    “…As the results show, during the study period: (1) Temporal Trends: annual PM2.5 concentrations exhibited significant declines, with BTH decreasing from 1004.71 μg/m<sup>3</sup> (2006) to 528 μg/m<sup>3</sup> (2020), YRD from 1434.81 μg/m<sup>3</sup> (2008) to 621 μg/m<sup>3</sup>, and PRD from 405.02 μg/m<sup>3</sup> (2007) to 292 μg/m<sup>3</sup>. …”
  13. 18133

    Table4_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.xlsx by Yifang He (18126257)

    Published 2024
    “…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”
  14. 18134

    Image2_Unveiling the molecular landscape of PCOS: identifying hub genes and causal relationships through bioinformatics and Mendelian randomization.tif by Yifang He (18126257)

    Published 2024
    “…Background<p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. …”
  15. 18135

    Table_1_Estimation of scrub typhus incidence and spatiotemporal multicomponent characteristics from 2016 to 2023 in Zhejiang Province, China.XLSX by Haocheng Wu (559031)

    Published 2024
    “…Background<p>China is one of the main epidemic areas of scrub typhus, and Zhejiang Province, which is located in the coastal area of southeastern China, is considered a key region of scrub typhus. However, there may be significant bias in the number of reported cases of scrub typhus, to the extent that its epidemiological patterns are not clearly understood. …”
  16. 18136

    Data Sheet 1_Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study.docx by Heinz Wiendl (237353)

    Published 2025
    “…IgG and IgM levels remained above the lower limits of normal in most participants. sNfL levels decreased, remaining reduced by M24. Significant reductions in the annualized combined unique active lesion count occurred from M2 onwards. …”
  17. 18137

    Data Sheet 2_Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study.csv by Heinz Wiendl (237353)

    Published 2025
    “…IgG and IgM levels remained above the lower limits of normal in most participants. sNfL levels decreased, remaining reduced by M24. Significant reductions in the annualized combined unique active lesion count occurred from M2 onwards. …”
  18. 18138

    Molecular signatures underlying multisensory gamma stimulation-associated cognitive benefits in the hippocampus. by Md Rezaul Islam (19649494)

    Published 2025
    “…<p><b>A)</b> Experimental scheme for the single nuclei RNA-seq experiment in Ts65Dn mice <b>B)</b> Unbiased clustering of hippocampal snRNA-seq data for 15884 nuclei represented on a UMAP. …”
  19. 18139

    Table 1_Serum levels of interleukin-17, -18, -22, and -25 in patients with bullous pemphigoid before and after treatment.xlsx by Xinyi Hong (8181177)

    Published 2025
    “…A binary multivariate logistic regression analysis indicated the statistically significant effect of IL-18, IL-25, or EOS on BP (p < 0.001). …”
  20. 18140

    Table 3_An analysis of the global burden of gallbladder and biliary tract cancer attributable to high BMI in 204 countries and territories: 1990–2021.xlsx by Zhuowen Hu (20431616)

    Published 2024
    “…High Body Mass Index (BMI) is a significant risk factor, contributing substantially to GBTC mortality and Disability-Adjusted Life Years (DALYs). …”